With the dual roles of DC-SIGN as a potential SARS-CoV-2 gateway and an innate immune initiator, DCs may play important and complicated roles in SARS-CoV-2 infection and clinical outcomes of COVID-19 patients. Here, CD209 is linked to COVID-19.